1. Introduction {#sec1}
===============

Genomic imprinting is an epigenetic process resulting in monoallelic parent-of-origin dependent gene expression, regulated by differential DNA methylation ([@bib29]). DNA methylation is established in only one of the parental germ lines on specific regulatory regions, called gametic differentially methylated regions (gDMRs). Methylation analysis of gDMRs in somatic cells typically shows \~50 percent methylation, as one parental allele is fully methylated whereas the other one is unmethylated. This differential DNA methylation is stable throughout development and cellular differentiation. The process of transcription plays an essential role in the establishment of DNA methylation at gDMRs and in the regulation of imprinted gene expression by transcriptional interference. Both levels of regulation by transcription have been observed at the Prader-Willi syndrome (PWS)/Angelman syndrome (AS) imprinted gene cluster on human chromosome 15 ([Figure 1](#fig1){ref-type="fig"}A). The gDMR resides in a CpG island at the *SNURF-SNRPN* promoter/exon 1, which becomes methylated in the female germ line only ([@bib29]). Maternal-only methylation of the PWS-SRO is seen after next generation bisulfite sequencing of DNA extracted from peripheral blood cells, with \~50% of the reads representing the methylated maternal allele and \~50% of reads representing the non-methylated paternal allele ([Figure 1](#fig1){ref-type="fig"}B). In humans, the gDMR is part of a bipartite imprinting center, which consists of the AS-SRO (Angelman syndrome - shortest region of overlap) and the PWS-SRO (Prader-Willi syndrome -- shortest region of overlap), the latter of which is identical with the gDMR at the *SNURF-SNRPN* promoter ([@bib22]). The upstream AS-SRO serves as oocyte-specific promoter initiating transcriptional read-through resulting in establishment of DNA methylation at the PWS-SRO ([Figure 1](#fig1){ref-type="fig"}C, [@bib37]; [@bib38]). Transcription from *Snrpn* upstream promoters is also essential for imprint establishment in the mouse ([@bib54]). DNA methylation of the PWS-SRO on the maternal chromosome represses transcription of *MRKN3*, *MAGEL2*, *NDN*, *SNRPN* and *SNHG14,* which serves as a host gene for snoRNAs. These genes are only active and transcribed from the paternal chromosome ([Figure 1](#fig1){ref-type="fig"}A, [@bib29]). In neurons, *SNHG14* transcription overlaps the *UBE3A* gene, which is transcribed from the opposite strand ([@bib30]; [@bib35]; [@bib49]). As shown in the mouse, the convergent promoter arrangement of *Snhg14*and *Ube3a* leads to silencing of the paternal *Ube3a* allele as a result of RNA polymerase collision ([Figure 1](#fig1){ref-type="fig"}D; [@bib42]; [@bib43]). However, the *Ube3a* promoter does not become methylated upon silencing ([@bib42]). Similar to silencing of paternal *Ube3a* by *Snhg14*, predominant maternal expression of *Commd1* at the murine imprinted *Commd1/Zrsr1* locus is caused by sense -- antisense transcriptional interference and transcriptional suppression of *Commd1* on the paternal allele ([@bib31]). At the human *RB1* locus, transcription is biased towards the maternal allele, which is likely to be regulated by transcriptional interference between regular *RB1* and the alternative transcript *RB1-E2B* starting in intron 2 of *RB1* ([@bib32]). Transcriptional interference and transcriptional read-through can occur together, as has been demonstrated at the murine imprinted *Igf2r/Airn* locus. Here, stable repression of the paternal *Igf2r* promoter by DNA methylation is dependent on traversing transcription of *Airn* ([@bib4], [@bib36]).Figure 1Imprint establishment and silencing of paternal *UBE3A* by transcription. A) Schematic view of PWS/AS locus on human chromosome 15. Imprinted expression in neurons is shown on the maternal (mat) and paternal (pat) chromosome. Vertical bars and boxes: exons, arrows: active transcription and direction, grey horizontal lines: CpG islands, lollipop: filled: methylated, white: not methylated, SRO: shortest region of overlap. B) Heatmap as output of quantitative methylation analysis by next-generation bisulfite sequencing. PWS-SRO was analyzed in blood of a normal control person. 66.734 total reads are depicted in rows, 21 CpG sites in columns. Methylated CpGs appear in red, non-methylated CpGs in blue. Fully methylated reads (red) at the top are derived from the maternal allele, non-methylted reads (blue) at the bottom from the paternal allele, resulting in 45.7% overall methylation. C) Imprint establishment at PWS-SRO by transcriptional read-through initiating at AS-SRO in growing oocytes (bottom), but not in primordial germ cells (top). D) Silencing of paternal *UBE3A* by RNA polymerase II collision between *SNHG14* and *UBE3A* transcripts in intron 4.Figure 1

The necessity of transcription through the gDMR for establishment of DNA methylation has further been demonstrated at the imprinted *Kcnq1*, *Gnas* and *Zrsr1* loci in mouse oocytes ([@bib24]; [@bib31]; [@bib52]). Patients carrying mutations that abolish activity of the *KCNQ1* promoter on their maternally inherited chromosome 11 lack DNA methylation at the gDMR *KCNQ1OT1:TSS-DMR* imprinting center and develop the imprinting disorder Beckwith-Wiedemann syndrome ([@bib17]; [@bib8]). This suggests the need for *KCNQ1* transcription through the gDMR for establishment of DNA methylation in human oocytes. DNA methylation at gDMRs in the oocyte is likely to be established by the same mechanism as gene-body methylation during active transcription ([@bib34]; [@bib9]). Actively transcribed genes or regions are marked by the histone modification H3K36me3 (trimethylation of lysine 36 of histone H3), which results in recruitment of de novo DNA methyltransferases and the deposition of DNA methylation in gene bodies ([@bib15]; [@bib25]). In general, factors needed for DNA methylation mediated by transcription are therefore present in germ cells and somatic cells. However, Joh et al. demonstrated that de novo DNA methylation of the *Zrsr1*-DMR did only occur in the growing mouse oocyte but not during post-fertilization development ([@bib31]). This points to oocyte-specific factors needed for imprint establishment.

Transcriptional interference is defined as the negative influence of one transcriptional process onto another in cis ([@bib51]). Pervasive transcription of the human genome and the assumption that about 40% of all transcripts arise from overlapping genomic sequences has introduced transcriptional interference as an important regulatory process ([@bib16]). Transcriptional interference arises at tandem and convergent promoters and involves different mechanisms, eg. promoter occlusion, roadblocking and RNA polymerase collision ([@bib51]). The causal association of transcription traversing active promoters with induction of DNA methylation was supported further by genomic deletions of transcription termination signals found in patients. In Lynch syndrome, which is hereditary non-polyposis colorectal cancer (HNPCC), deletions of the termination signal of the upstream gene *EPCAM* resulted in transcriptional read-through of *EPCAM* across the *MSH2* promoter in sense direction and induction of DNA methylation (Figure S1A; [@bib5]). In α-thalassemia a genomic deletion including the genes *HBA1*, *HBQ1* and the 3′-end of the downstream gene *LUC7L* resulted in an elongated *LUC7L* transcript that overlapped the *HBA2* gene in antisense direction. This led to DNA methylation and stable silencing of *HBA2* (Figure S1B; [@bib57]). In rare cases of the vitamin B12 metabolism cblC disorder, which is caused by defects in *MMACHC* gene expression, a splice site mutation in the neighbouring *PRDX1* gene leads to skipping of its last exon including the poly(A) signal and continuous transcription in antisense across the *MMACHC* gene and its promoter ([@bib2]). This resulted in DNA methylation and silencing of *MMACHC* expression on the allele carrying the mutation in *PRDX1*. This demonstrates that genetic lesions in neighboring genes, which lead to aberrant transcription elongation across gene promoters, can induce DNA methylation.

These findings resulted in our hypothesis that somatic cells harbor all necessary factors for de novo DNA methylation by transcriptional read-through. Transcriptional read-through at an active promoter will result in transcriptional interference and might lead to DNA methylation. How these processes are linked, and which factors are needed or make promoters susceptible to the regulation by transcriptional read-through and transcriptional interference is not entirely clear. Current systems investigating transcriptional interference often employ yeast, bacteria or synthetic systems ([@bib18]; [@bib28]; [@bib50]). Although these systems allow straight forward generation of constructs and the use of reporter systems for read-out, they are not suited to study the complex epigenetic mechanisms occurring as a consequence of transcriptional read-through and interference in mammalian cells. DNA methylation at CpG sites is absent in yeast and bacteria ([@bib23]; [@bib41]). Moreover, in transient transfection systems, plasmid-based constructs do not integrate into the genome and are not influenced by large-scale chromatin interactions. A recent study employed mouse embryonic stem cells to study acquisition of DNA methylation at intragenic promoters by transcription ([@bib3]). The authors showed that methylation of intragenic CpG island promoters is related to traversing transcription, the presence of the histone modification H3K36me3 and relative promoter strength. Especially, induction of methylation was related to differentiation, mainly because transcription of the main promoter increased ([@bib3]). This study also supports the notion that germ line passage is not needed for transcription mediated establishment of DNA methylation.

Here we describe the generation of a simple and versatile human cell culture system to study transcriptional interference, transcriptional read-through and de novo DNA methylation. In this system, any promoter of interest (test promoter) can be cloned downstream of the inducible CMV promoter and the construct is inserted at one and the same genomic locus in the host cells, thus allowing comparisons between different experiments. Here, we tested the promoters of the non-imprinted *HBA2* and *MSH2* genes and the imprinted *SNRPN* and *UBE3A* genes.

2. Materials and methods {#sec2}
========================

2.1. Generation of constructs {#sec2.1}
-----------------------------

In brief, selected promoter fragments were amplified from genomic DNA of Flp-In T-REx 293 cells (Thermo Fisher Scientific, \#78007; *UBE3A*, *MSH2* and *SNRPN*) or from plasmid pZErO-*HBA*4kb*Xho*I (*HBA2*) and verified by sequencing. Inserted and endogenous promoter sequences can be discriminated by single nucleotide variants. Promoter fragments were inserted into the pGL4.10 luciferase reporter vector (Promega, \#E6651) and tested for promoter activity. The targeting vector for Flp-In T-REx cells, pcDNA5/FRT/TO (Thermo Fisher Scientific, \#V6520-20), was modified and contains the rabbit β-globin (*ocHBB2*) partial exon 2--intron 2--exon 3 array, in which a cloning linker or an EcoRV restriction site was inserted in intron 2. The cloning linker and the EcoRV restriction site were used to integrate the minigenes that consist of a promoter fragment driving *EGFP* expression and promoter sequences containing exon 1 of the gene of interest (*MSH2*^S^\_ex1, *SNRPN*^S^\_ex1), respectively. To enlarge the distance between CMV and test promoters, constructs for *SNRPN*^S^\_GFP, *SNRPN*^S^\_ex1 and *MSH2*^S^\_ex1 contain a spacer sequence upstream of *ocHBB2* exon 2. Primers are listed in Table S1 and plasmids generated and used in this study are listed in Table S2. A detailed description of the cloning procedure is given in Supplementary Methods.

2.2. Generation and induction of stable cell lines {#sec2.2}
--------------------------------------------------

Flp-In T-REx 293 and Flp-In T-REx HeLa cells (Thermo Fisher Scientific) were maintained in Flp-In medium (DMEM,10% FBS, 1% penicillin/streptomycin (all Thermo Fisher Scientific, \#41966, \#10270, \#15140122), 15 μg/ml blasticidin (Invivogen, \#ant-bl-1)) containing zeocin (50 μg/ml for Flp-In T-REx 293 and 200 μg/ml for Flp-In T-REx HeLa; Invivogen, \#ant-zn-1). For transfection, 1.5 × 10^5^ cells/well were seeded in a 6-well plate (medium without antibiotics) and transfected using Lipofectamine 2000 reagent (Flp-In T-REx 293; Thermo Fisher Scientific, \#11668019) or Fugene HD (Flp-In T-REx HeLa; Promega, \#E2311) with 100 ng of minigene-BV-plasmids and 900 ng of plasmid pCSFLPe (Table S2). 24 hours after transfection cells were transferred to four 10 cm cell culture dishes. After another 24 h medium was changed to Flp-In medium with hygromycin (100 μg/ml for Flp-In T-REx 293, 250 μg/ml for Flp-In T-REx HeLa; Invivogen, \#ant-hg-1). After 10 to 14 days of selection, single colonies were isolated and expanded. Success of minigene integration was monitored by *LacZ* staining of fixed cells (1% formaldehyde, 0.2% glutaraldehyde in PBS) stained with 5 mM K~3~\[Fe(CN)~6~\], 5 mM K~4~\[Fe(CN)~6~\], 2 mM MgCl~2~, 1 mg/ml X-Gal in PBS for 2.5 h at 37 °C. Non-recombined cells stain blue, recombined cells do not. Three independent clonal cell lines per construct were used for further experiments. Induction of the CMV promoter was achieved by adding doxycycline to the medium (Sigma, \#D9891, final concentration 1 μg/ml). Under induction, including non-induced control cells, medium was prepared using tetracycline-free FBS (Thermo Fisher, \# 16000-044) and changed daily.

2.3. Isolation of DNA, RNA and protein {#sec2.3}
--------------------------------------

Isolation of DNA, RNA and protein was performed on 2 × 10^6^ Flp-In T-REx 293 cells either simultaneously using the AllPrep DNA/RNA/Protein Mini Kit (Qiagen, \#80004) or separately using RNeasy Mini Kit (Qiagen, \#74104) and FlexiGene DNA Kit (Qiagen, \#51206) according to manufacturer\'s instructions. Protein lysates were prepared in lysis buffer (500mM NaCl, 20mM Tris pH8.8, 1mM EDTA, 0.5% NP40, 1x Halt proteinase and phosphatase inhibitor (Thermo Fischer, \#78442)). Samples were incubated on ice for 30 min with vortexing every 10 min. After centrifugation at 14.000 rpm for 20 min by 4 °C, the supernatant was aliquoted and frozen at -80 °C.

2.4. Quantitative RT-PCR {#sec2.4}
------------------------

Total RNA was treated with RQ1 RNase-Free DNase (Promega, \#M6101) and reverse transcribed into cDNA using the GeneAmp RNA PCR core kit and oligo-dT primers (Thermo Fisher Scientific, \#N8080143). Quantitative real-time PCR was performed on a Roche LightCycler II using LightCycler 480 Probes Master Mix (Roche, \#04887301001), probes from Roche universal probe library (UPL) and corresponding primers at following conditions: 95 °C, 10 min; 45 cycles 95 °C, 10 s, 60 °C, 30 s, 72 °C, 1 s; 40 °C, 30 s. Triplicate measurements were normalized to mean expression of *GAPDH* and calibrated to indicated samples. Primers and probes are listed in Table S1.

2.5. Western blot {#sec2.5}
-----------------

Proteins were resolved on 10% SDS polyacrylamide gels and transferred to nitrocellulose membrane (Thermo Fisher Scientific, \#GE10600016) by semi dry transfer. Membranes were blocked in 5% milk powder (Roth, \#T145-2) or 5% Bovine Serum Albumin (BSA, Roth \#8076.2) and incubated over night at 4 °C with primary antibodies (GFP: CST, \#2956, 1:1000; GAPDH: CST, \#2118, 1:5000, DNMT3A: Origene, \#TA336580, 1:100; DNMT3L: Novus Biologicals, \#H00029947-D01P, 1:500; -tubulin: CST, \#2146S,1:1000). Detection was performed using HRP-conjugated secondary antibodies (Thermo Fisher Scientific, goat anti-rabbit \#32460 and goat anti mouse \#32430), Super Signal West Dura Extended Duration Substrate (Thermo Fisher Scientific, \#34075) and development on X-ray film or INTAS Chemostar Touch 21.5 (1 × 1 binning or 4 × 4 binning, sequence images every 30sec). Images of complete membranes are displayed in Figures S11 - S13.

2.6. Analysis of DNA methylation {#sec2.6}
--------------------------------

500 ng of genomic DNA was converted using the EZ DNA Methylation-Gold kit (Zymo Research, \#D5006) according to manufacturer\'s instructions. For the following PCR reaction, 1 μl of the bisulfite-converted DNA was mixed with 0.4 μM tagged, amplicon-specific primers and HotStarTaq Master Mix (Qiagen, \#203443) in a total volume of 25 μl. PCR conditions were 95 °C for 15 min, (95 °C for 30 s, annealing temperature for 30 s, 72 °C for 45 s) 45 cycles, 72 °C for 10 min. For analysis by Sanger sequencing, PCR products were sequenced using tag-specific primers on an ABI 3130XL Genetic Analyzer. Sequencing analysis was performed using Geneious R10 (Biomatters). In the alignment, methylated cytosine residues appeared as cytosine, whereas non-methylated cytosine residues appeared as thymine. Detailed methylation status of test promoter region was determined by next generation amplicon sequencing. First PCR was carried out as mentioned above with 1 to 3μl bisulfite-converted DNA. PCR products were re-amplified by tag-specific multiplex identifier (MID) or index primer sets and the following PCR conditions: 95 °C for 15 min, (95 °C for 30 s, annealing temperature for 30 s, 72 °C for 45 s) 45 cycles (Flp-In T-REx 293) or 55 (Flp-In T-REx HeLa) cycles, 72 °C for 10 min. Processing of samples on the Roche 454 Junior (Flp-In T-REx 293) or MiSeq (Flp-In T-REx HeLa) platform and analysis using the Amplikyzer program was performed as described ([@bib48]; [@bib59]). The program checks efficiency of bisulfite conversion by determining the C/T conversion rate at non-CpG cytosines. Only reads with a conversion rate \>95% were included in the analysis. The output is represented as heatmaps, with reads in rows, single CpG sites in columns. Methylated CpGs are shown in red, non-methylated CpGs in blue ([Figure 1](#fig1){ref-type="fig"}B). Primers are listed in Table S1.

2.7. Lentiviral transduction {#sec2.7}
----------------------------

For lentivirus production, HEK293FT cells were seeded at 5 × 10^5^ cells/10cm dish in DMEM complete (DMEM, 10% FBS, 1% penicillin/streptomycin (all Thermo Fisher Scientific, \#41966, \#10270, \#15140122)). 4 hours before transfection medium was changed into medium without antibiotics. Transfection was performed 24 h after seeding, using Fugene HD (Promega, \#E2311), lentiviral packaging plasmids (1.5 μg VSV-G/pMD2, 3 μg pSPAX, Table S2; provided by Alexander Schramm, University Hospital Essen) and 3μg of plasmid pLJM1-DNMT3A2 (Table S2; provided by Wolfgang Wagner, University Hospital Aachen, [@bib21]). 24 hours after transfection, DMEM complete medium was changed. 72 hours after transfection supernatant containing virus particles was harvested, filtered (0.45μm PES membrane filter; VWR, \#514-0075) and stored at -80 °C. For transduction, Flp-In T-REx HeLa were seeded at 6 × 10^4^ cells/well in a 6-well plate and treated with 500μl virus supernatant 24 h after seeding. Selection of stable Flp-In T-REx HeLa DNMT3A2 cells was started 48 h after transduction by maintaining cells in culture medium with 0.2 μg/ml puromycin (Sigma, \#P8833).

2.8. Transient transfections {#sec2.8}
----------------------------

For transient transfection, Flp-In T-REx HeLa were seeded at 2 × 10^5^ cells/well in a 6-well plate in tetracycline-free medium and transfected using Fugene HD (Promega, \#E2311), 500 ng of pLJM1-DNMT3A2 plus 500ng pCMV6-XL5-DNMT3L plasmids (Table S2). 48 hours after transient transfection, CMV promoter activity was induced for three days by doxycycline (Sigma, \#D9891, final concentration 1 μg/ml) with daily medium change.

2.9. Analyses and statistics {#sec2.9}
----------------------------

Analyses and graphical display of qPCR results were performed in GraphPad Prism 8 (GraphPad Software). Unless otherwise stated, Mann-Whitney test was used for testing statistical significance. Significance levels: ns: not significant, \*p ≤ 0.05, \*\*p ≤ 0.01, \*\*\*p ≤ 0.001, \*\*\*\*p ≤ 0.0001.

3. Results {#sec3}
==========

The human model for investigating the effect of transcriptional read-through on gene repression and acquisition of DNA methylation was established in the Flp-In T-REx cell system, which carries stable integrations of an expression cassette for the tetracycline repressor and a single FRT site ([Figure 2](#fig2){ref-type="fig"}A). A targeting vector is used to integrate a gene of interest under control of the doxycycline inducible CMV promoter by recombination via the FRT site. Here, the targeting vector does not contain a cDNA of interest, but a fragment of the rabbit β-globin gene (*ocHBB2*; exon 2--intron 2--exon 3, [@bib36]; [@bib53]) ([Figure 2](#fig2){ref-type="fig"}B). Test promoters driving expression of reporter transcripts (*EGFP* or *exon1/3*, see below) were integrated into intron 2 of *ocHBB2*. Expression of the transcript *ocHBB2* exon 2/exon 3 (designated *ocHBB2* throughout the text) is driven by the CMV promoter upon induction with doxycycline. The benefit of this system is that all integrations occur at the same site in the genome, avoiding position effects associated with random integrations. In addition, embedding the targeting construct into the genome ensures packaging into the nucleosome environment of the integration site and enables regulation by histone modifications and DNA methylation.Figure 2Site-specific integration into the genome of Flp-In T-REx cells. A) In Flp-In T-REx host cells a *Flp recombinase* target site (FRT) and the fusion selection gene LacZ-zeocin (blue) under the SV40 promoter was randomly integrated in single copy into the genome. B) Targeting construct. Backbone of pcDNA5/FRT/TO carries an FRT site, the hygromycin resistance gene and the inducible CMV promoter (CMV). The *ocHBB2* exon 2 - intron 2 - exon 3 array was integrated downstream of the CMV promoter. The HindIII site was used to integrate spacer sequence, EcoRV was used to integrate test promoters. C) After Flp-mediated recombination, the ATG is now used for translation of the hygromycin resistance gene. Inducible and test promoters are integrated at a unique genomic position. Presence of spacer depends on construct. Specific constructs are depicted at corresponding Figures.Figure 2

3.1. Investigation of transcriptional interference {#sec3.1}
--------------------------------------------------

For studying transcriptional interference, a minigene consisting of test promoter and *EGFP* was inserted into intron 2 of *ocHBB2* either in sense or in antisense direction ([Figure 3](#fig3){ref-type="fig"}A). In sense orientation, inserted transcripts used the poly-adenylation (pA) signal of the *ocHBB2* gene fragment. For antisense constructs, we introduced a pA signal at the 3′ end of *EGFP*. Promoter fragments used were *UBE3A*, *MSH2*, *HBA2* and *SNRPN* (Figure S2). The *HBA2* promoter was amplified as *HBA2-*short, which contains the region directly upstream of the *HBA2* transcriptional start site, and *HBA2-*long, which contains the full CpG island. All promoter fragments contained single nucleotide variants to enable discrimination between introduced and endogenous promoters in DNA methylation analyses. Promoter activity of the amplified and cloned promoter fragments was confirmed by luciferase reporter assays (Figure S3A). Addition of doxycycline had no influence on the activity of promoter fragments (Figure S3B).Figure 3Expression and methylation analyses in Flp-In T-REx 293. A) Targeting constructs. Dark grey: upstream CMV promoter, light grey: minigene consisting of test promoter *(MSH2*, *HBA2, UBE3A*) and *EGFP*, white: exons 2 and 3 of *ocHBB2*, triangle: poly(A) signal, black bar: linker for integration of minigenes, arrows: primers for qRT-PCR. B) Expression of *ocHBB2* (top) and *EGFP* (bottom) upon induction with doxycycline, black: 3 days, white 14 days. Short line indicates mean fold induction/reduction, number below indicates fold change relative to uninduced state, dotted line: uninduced set to 1. Symbols: independent clones. C) DNA methylation of test promoters before and after induction (-/+ dox). Blue: not methylated, red: methylated, CGs in columns, reads in rows. Overall percentage of DNA methylation and number of reads are indicated. In comparison to the example plot in [Figure 1](#fig1){ref-type="fig"}B, there are no methylated (red) reads. D) Expression of *ocHBB2* (top) and *EGFP* (bottom) after 3 days induction (dark grey bars) and after 3 days without induction (light grey bars). Numbers below indicate average fold change between these two states. Dotted line: uninduced state set to 1.Figure 3

Four stable cell lines on the Flp-In T-REx 293 background were generated. Corresponding to the endogenous loci, the minigenes (promoter plus *EGFP*) were inserted in antisense (*UBE3A*, *HBA2*) and sense (*MSH2, SNRPN*) orientation relative to the CMV promoter, designated *UBE3A*^AS^, *HBA2*^AS^\_short, *HBA2*^AS^\_long, *MSH2*^S^ and *SNRPN*^S^\_GFP. Data for *HBA2*^AS^\_long are shown in Figure S4 and for *SNRPN*^S^\_GFP in Figure S5. For each cell line, three independently generated clones were used for experiments. First, the influence of CMV promoter induction on expression of the reporter gene *EGFP* was assessed. CMV promoter activity was induced for three and 14 days, and induction of *ocHBB2* was observed in all cell lines. The level of induction was comparable in all cell lines. But in *MSH2*^S^, cell clone dependent variability was observed ([Figure 3](#fig3){ref-type="fig"}B). Without induction of the CMV promoter, *EGFP* expression was detected on RNA level in all cell lines and at the protein level in lines *UBE3A*^AS^, *HBA2*^AS^\_short, *HBA2*^AS^\_long, but not in *MSH2*^S^ and *SNRPN*^S^\_GFP ([Figure 3](#fig3){ref-type="fig"}B, S4, S5, S6). Upon induction of the CMV promoter by doxycycline, *EGFP* expression decreased in all cell lines, with strongest effect observed in *UBE3A*^AS^ on RNA and protein level ([Figure 3](#fig3){ref-type="fig"}B, S6), which suggests induction of transcriptional interference. Again, *MSH2*^S^ showed highest variability, which was cell clone dependent. *ocHBB2* induction and *EGFP* repression levels did not change during the 14-day time course of the experiment, suggesting rapid establishment of a steady-state level after doxycycline induction. In patient tissue, *HBA2* and *MSH2* promoters become silenced permanently by DNA methylation following transcriptional interference. In our model, none of the *UBE3A*^AS^, *HBA2*^AS^\_short, *HBA2*^AS^\_long and *MSH2*^S^ promoters became methylated after three and 14 days of induction as shown by next generation bisulfite sequencing analysis ([Figure 3](#fig3){ref-type="fig"}C, S4C). *SNRPN*^S^\_GFP also did not acquire DNA methylation as analyzed by Sanger sequencing after bisulfite conversion (data not shown). Therefore, reversibility of *EGFP* repression was examined. Cell lines *UBE3A*^AS^, *HBA2*^AS^\_short, *HBA2*^AS^\_long and *SNRPN*^S^\_GFP were induced with doxycycline for three days and analyzed after another three days without induction ([Figure 3](#fig3){ref-type="fig"}D, S4D S5C). *MSH2*^S^ cell lines were not included because of the high variability in effects ([Figure 3](#fig3){ref-type="fig"}B). Three days of *ocHBB2* induction resulted in decreased expression of *EGFP*, which was reversed during the following three days without induction ([Figure 3](#fig3){ref-type="fig"}D, S4D, S5C). This demonstrated that repression of *EGFP* is directly dependent on transcription of *ocHBB2*.

3.2. Attempts to induce DNA methylation by transcriptional read-through {#sec3.2}
-----------------------------------------------------------------------

For further studying transcriptional interference at tandem promoters and the establishment of DNA methylation by transcriptional read-through, we used Flp-In T-REx HeLa cells, as these expressed *DNMT3A* at a higher level than Flp-In T-REx 293 cells (Figure S7). The targeting vector was modified to include a 1kb spacer element, which enhances the distance between the upstream inducible CMV promoter and the integrated downstream promoter. In addition, the *EGFP* reporter gene was omitted ([Figure 4](#fig4){ref-type="fig"}A). The promoter sequences, including endogenous exon 1 of *MSH2* and *SNRPN* were inserted into intron 2 of the *ocHBB2* gene fragment in tandem orientation to the upstream CMV promoter. The CMV promoter again drove transcription of *ocHBB2*, whereas the *MSH2* and *SNRPN* promoters drove expression of a transcript consisting of the respective endogenous exon 1 and exon 3 of *ocHBB2* (designated exon 1/3 transcript) ([Figure 4](#fig4){ref-type="fig"}A). Single nucleotide variants were introduced into both promoter fragments to enable discrimination from the endogenous promoter sequences in methylation analyses. The *MSH2* promoter fragment was additionally modified at four cryptic splice sites to suppress aberrant splicing of *ocHBB2* exon 2 on *MSH2* exon 1 (Figure S2), which had been observed in preliminary experiments (not shown). Activity of promoter fragments was tested in luciferase assays and doxycycline had no influence on promoter activity (Figure S3).Figure 4Expression analyses in Flp-In T-Rex HeLa. A) Targeting constructs. Dark grey: upstream CMV promoter, black: spacer sequence, light grey: test promoter *(MSH2, SNRPN*), white: exons of *ocHBB2* and endogenous exon 1, triangle: poly(A) signal, arrows: primers for qRT-PCR. B) Expression of *ocHBB2* (top) and exon1/3 (bottom) upon induction with doxycycline: black: 3 days, white: 14 days. Short line indicates mean fold induction/reduction and numbers below indicate fold change relative to uninduced state (set to 1, dotted line). Symbols: independent clones. C) Expression of *ocHBB2* (top) and *EGFP* (bottom) after 3 days induction (dark grey bars) and again after 3 days without induction (light grey bars). Numbers below indicate average fold change between these two states. Dotted line: uninduced state set to 1.Figure 4

The promoter constructs were used to establish two stable Flp-In T-REx HeLa cell lines, designated *MSH2*^S^\_ex1 and *SNRPN*^S^\_ex1. Per cell line, expression was analyzed in three independently generated clones at three and 14 days of induction by doxycycline. In *SNRPN*^S^\_ex1, transcription of *ocHBB2* was induced about 2-fold, whereas *MSH2*^S^\_ex1 reached a mean induction level of almost 24-fold ([Figure 4](#fig4){ref-type="fig"}B). Induction was comparable at both time points and among independent clones. Transcription of exon 1/3 transcript driven by *SNRPN* and *MSH2* promoter fragments was decreased upon three and 14 days of induction, compared to the not induced state ([Figure 4](#fig4){ref-type="fig"}B). Induction of *ocHBB2* correlated with suppression of *MSH2* and *SNRPN* promoter activity, indicating silencing by transcriptional read-through. However, silencing was not followed by DNA methylation in any of the cell lines, as analyzed by bisulfite-based Sanger sequencing (data not shown). Decreased expression of *MSH2 and SNRPN* exon1/3 transcripts after three days of *ocHBB2* induction was reversed during the following three days without induction ([Figure 4](#fig4){ref-type="fig"}C). Repression of *MSH2 and SNRPN* exon1/3 was therefore directly dependent on *ocHBB2* transcriptional read-through.

Probably, the level of DNMT3A2 in Flp-In T-REx HeLa cells was not sufficient for induction of de novo DNA methylation. To increase the levels of DNMT3A2, a *DNMT3A2* expression cassette was stably integrated in Flp-In T-REx HeLa cells by lentiviral transduction, followed by integration of the *MSH2* and *SNRPN* promoter constructs. In these cell lines (*MSH2*^S^\_ex1_DNMT3A2 and *SNRPN*^S^\_ex1_DNMT3A2), increased *DNMT3A2* expression was detected at RNA but not protein level (Figure S8A, B). In these modified cell lines, induction of *ocHBB2,* repression of exon 1/3 and failure of DNA methylation acquisition were comparable to experiments in non-transduced Flp-In T-REx HeLa cells (Figures S8C, D). To obtain very high levels of DNTM3A2 and DNMT3L, these proteins were transiently overexpressed (Figure S9). Following transfection of the *MSH2*^S^\_ex1_DNMT3A2 and *SNRPN*^S^\_ex1_DNMT3A2 cell lines with *DNMT3A2* and *DNMT3L* expression plasmids, RNA and protein expression levels of the two proteins increased substantially (Figure S9, S10). Trends in expression changes of *ocHBB2* and repression of exon 1/3 transcripts were comparable to the previous experiments ([Figure 5](#fig5){ref-type="fig"}A). But again, analysis of DNA methylation by next-generation bisulfite sequencing showed no acquisition of DNA methylation in any cell line ([Figure 5](#fig5){ref-type="fig"}B).Figure 5Transient overexpression of DNMT3L and DNMT3A2. A) Expression of *ocHBB2* (top) and exon1/3 (bottom) upon induction with doxycycline in *MSH2*^S^-ex1_DNMT3A2 and *SNRPN*^S^\_ex1_DNMT3A2 for three days. Short line indicates mean fold induction/reduction, numbers below indicate fold change relative to uninduced state (set to 1, dotted line). Symbols: independent clones. Statistical analysis with Student t-test. B) DNA methylation of test promoters before and after induction (-/+ dox). Blue: not methylated, red: methylated, CGs in columns, reads in rows. Overall percentage of DNA methylation and number of reads are indicated. In comparison to the example plot in [Figure 1](#fig1){ref-type="fig"}B, there are no methylated (red) reads.Figure 5

4. Discussion {#sec4}
=============

We have developed a simple and versatile human cell culture system to study the role of transcription in gene silencing and de novo DNA methylation. Induction of upstream transcription of *ocHBB2* initiating at the CMV promoter consistently resulted in repression of the downstream inserted promoters. *MSH2* and *SNRPN* promoters were weak promoters inserted in tandem orientation, whereas *UBE3A* and *HBA2* were relatively strong promoters orientated antisense to the CMV promoter. Induction of *ocHBB2* reduced expression of the *EGFP* reporter gene in Flp-In T-REx 293 cells and of exon1/3 in Flp-In T-REx HeLa cells. Repression was dependent on *ocHBB2* transcription. We showed that the system is capable of modelling transcriptional interference, independently of cell line, orientation and strength of promoters. However, DNA methylation did not follow transcriptional repression in any of the generated cell lines.

Acquisition of DNA methylation as consequence of transcriptional read-through has been demonstrated at several genomic loci. In natural genomic context, transcriptional read-through is needed for establishment of gametic imprints (see introduction). The role of transcriptional read-through for establishment of DNA methylation was strengthened further by the observation of rare patients with α-thalassemia, Lynch syndrome and methylmalonic acidemia with homocystinuria type cblC ([@bib2]; [@bib5]; [@bib57]). These cases showed that somatic cells contain all factors necessary for the induction of DNA methylation. It consequently should be possible to mimic this mechanism in the somatic cell culture system described here.

De novo DNA methylation is mediated by the two DNA methyltransferases DNMT3A and DNMT3B. Knock-out of *Dnmt3A* and/or *Dnmt3B* is lethal in mice ([@bib46]). In humans, somatic mutations in *DNMT3A* and *DNMT3B* have been described in AML, Tatton-Brown-Rahmann syndrome and ICF syndrome ([@bib7]; [@bib58]; [@bib12]). DNMT3A and DNMT3B are very similar in structure and biochemically, their catalytic activity is enhanced on interaction with DNMT3L, which itself has no methyltransferase activity ([@bib56]). Both DNMTs were shown to bind to H3K36me in vitro (DNMT3A) or in vivo (DNMT3B) ([@bib15]; [@bib25]). Despite these similarities in structure and binding partners, in vivo studies showed that DNMT3A and DNMT3B have different functions and target specificities, depending on the cellular context. DNMT3A and DNMT3L are essential for establishment of DNA methylation in germ cells. In oocytes, establishment of maternal imprints and in sperm silencing of retrotransposons as well as establishment of paternal imprints are dependent on presence of these two factors ([@bib19]; [@bib20]; [@bib33]; [@bib56]). The function of DNMT3A in oocytes is dependent on presence of its cofactor DNMT3L and of SETD2, the histone methyltransferase catalyzing tri-methylation of H3K36 ([@bib20]; [@bib11]). In somatic cells, DNMT3A exhibited a preference for H3K36me2 rather than for H3K36me3 and acts independently of DNMT3L ([@bib10]). However, Duymich et al. showed that catalytically inactive isoforms of DNMT3B could act as cofactors for DNMT3A, possibly replacing DNMT3L in somatic cells ([@bib26]). H3K36me2 is established by NSD1 and enriched in intergenic regions. Ablation of NSD1 in mouse cells resulted in loss of H3K36me2, subsequent failure of recruitment of DNMT3A and hypomethylation of intergenic regions ([@bib10]). Specific patterns of DNA hypomethylation were also identified in the human overgrowth syndromes Sotos syndrome and Tatton-Brown-Rahmann syndrome, which are similar in phenotype and are caused by mutations in NSD1 and DNMT3A, respectively ([@bib1]; [@bib7]; [@bib10]). In contrast to Dnmt3A, Dnmt3B is essential for de novo DNA methylation during early embryogenesis, but not in germ cells ([@bib33]; [@bib46]). In mouse ES cells, specifically DNMT3B was recruited to sites of active transcription, which are marked by H3K36me3, mediated by SETD2 ([@bib15]). In our cell system, DNMT3A, DNMT3B, SETD2 and NSD1 were expressed, while DNMT3L was absent, as expected for differentiated cells (Figure S7C, [@bib40]; [@bib45]). However, simply elevating the expression level of DNMT3A2 and DNMT3L in the Flp-In T-REx HeLa system still did not result in establishment of DNA methylation at the tested promoters ([Figure 5](#fig5){ref-type="fig"}B, S8D).

The question is, if DNA methylation is not established or if it is not maintained. For maintenance of DNA methylation at imprinted genes, DNMT1 and ZFP57 are known to be essential. DNMT1 is expressed in our cell system, whereas ZFP57 is not (Figure S7C). ZFP57 is a KRAB-domain containing zinc finger protein, which binds to methylated DNA in a sequence specific manner and recruits DNA methyltransferases DNMT1, DNMT3A and DNMT3L via the mediator protein KAP1 ([@bib47]; [@bib13]). In mice, oocyte and zygotic Zfp57 is essential for maintenance of DNA methylation at imprinted regions during development ([@bib39]; [@bib55]). In humans, ZFP57 is not expressed in oocytes, but expression in early embryonic development is needed for methylation maintenance at specific imprinted differentially methylated regions, like *PLAGL1*:alt-TSS-DMR, *PEG3*:TSS-DMR and *GRB10*:alt-TSS-DMR ([@bib6]; [@bib44]).

Since provision of DNMT3A2 and DNMT3L at high levels did not result in DNA methylation as consequence of transcriptional read-through at the analyzed promoters, we speculate that the genomic context could be a problem in the cell systems. The Flp-In T-REx cell system allows integration of constructs as a single copy using an FRT-site at a fixed, but unknown, genomic position. Therefore, we can exclude position effects caused by different genomic integration sites. Unlike many other transgenes, our constructs were not methylated by a host-defense mechanism, but also not by induction of transcriptional read-through. However, the cell culture system described here does not reflect the normal genomic environment at the individual loci. At the *SNURF-SNRPN* locus, the distance between the upstream AS-SRO and PWS-SRO is 35kb. In Lynch syndrome patients the distance between *EPCAM* and *MSH2* promoter is about 16kb. The distance between the inducible upstream CMV promoter and the investigated test promoter in our cell system ranges from 211 to 1282 base pairs, which is far less than observed in natural context. This could result in steric hindrance of protein complexes that need access for transcription, modifying histones and establishing DNA methylation.

Another explanation for failure to induce DNA methylation may relate to the strength of the CMV and test promoters and the kinetics of transcription of the constructs. It is possible that de novo methylation occurs only within a narrow window of the relative strength of the upstream and downstream promoters, which is met at the endogenous imprinted and disease loci, but not in our constructs.

In summary, we have established a cell culture system to examine transcriptional interference and transcriptional read-through of human promoters in somatic cells. The strength of our system is that there are no position effects and that transcription from one promoter is inducible by doxycycline. We show that transcriptional interference leads to transient repression of the sensitive promoter, but that transcriptional read-through is not sufficient for inducing DNA methylation. We note that transcriptional read-through is also not sufficient to induce an epigenetic switch in the silencing activity of Polycomb response elements ([@bib27]). Establishment of DNA methylation is a complex process, which requires the presence of specific factors at the right amount and the right time. Probably, it also depends on the genomic context of the target region including adjacent regulatory elements as well as the strength of the transcription processes. We recommend conducting further investigations into the role of the genomic context, for example by replacing regular promoters by an inducible promoter. With the advent of CRISPR/Cas9 genome engineering such experiments could be done, if the integrated promoter is not silenced by the host-defense system.
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